CONMED PE Ratio 2010-2024 | CNMD
Current and historical p/e ratio for CONMED (CNMD) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. CONMED PE ratio as of January 21, 2025 is 17.45.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| CONMED PE Ratio Historical Data |
| Date |
Stock Price |
TTM Net EPS |
PE Ratio |
| 2025-01-17 |
67.69 |
|
16.08 |
| 2024-09-30 |
71.92 |
$4.21 |
17.08 |
| 2024-06-30 |
69.14 |
$3.14 |
22.02 |
| 2024-03-31 |
79.64 |
$2.61 |
30.51 |
| 2023-12-31 |
108.64 |
$2.04 |
53.25 |
| 2023-09-30 |
99.87 |
$1.85 |
53.98 |
| 2023-06-30 |
134.32 |
$2.83 |
47.46 |
| 2023-03-31 |
102.51 |
$-3.25 |
0.00 |
| 2022-12-31 |
87.30 |
$-2.84 |
0.00 |
| 2022-09-30 |
78.77 |
$-2.95 |
0.00 |
| 2022-06-30 |
93.89 |
$-3.96 |
0.00 |
| 2022-03-31 |
145.34 |
$2.10 |
69.21 |
| 2021-12-31 |
138.49 |
$1.94 |
71.39 |
| 2021-09-30 |
127.62 |
$2.00 |
63.81 |
| 2021-06-30 |
133.85 |
$1.76 |
76.05 |
| 2021-03-31 |
127.00 |
$0.39 |
325.64 |
| 2020-12-31 |
108.75 |
$0.28 |
388.38 |
| 2020-09-30 |
76.24 |
$-0.04 |
0.00 |
| 2020-06-30 |
69.61 |
$-0.04 |
0.00 |
| 2020-03-31 |
55.22 |
$1.11 |
49.75 |
| 2019-12-31 |
107.52 |
$0.95 |
113.18 |
| 2019-09-30 |
92.28 |
$1.00 |
92.28 |
| 2019-06-30 |
81.96 |
$0.97 |
84.50 |
| 2019-03-31 |
79.48 |
$1.08 |
73.60 |
| 2018-12-31 |
61.19 |
$1.41 |
43.40 |
| 2018-09-30 |
75.28 |
$2.52 |
29.87 |
| 2018-06-30 |
69.39 |
$2.58 |
26.89 |
| 2018-03-31 |
59.87 |
$2.12 |
28.24 |
| 2017-12-31 |
48.03 |
$1.99 |
24.14 |
| 2017-09-30 |
49.25 |
$0.60 |
82.09 |
| 2017-03-31 |
41.37 |
$0.44 |
94.02 |
| 2016-12-31 |
40.94 |
$0.52 |
78.74 |
| 2016-09-30 |
36.97 |
$0.56 |
66.02 |
| 2016-06-30 |
43.83 |
$0.62 |
70.69 |
| 2016-03-31 |
38.33 |
$0.79 |
48.52 |
| 2015-12-31 |
40.07 |
$1.10 |
36.43 |
| 2015-09-30 |
43.21 |
$1.23 |
35.13 |
| 2015-06-30 |
52.54 |
$0.98 |
53.61 |
| 2015-03-31 |
45.37 |
$1.08 |
42.01 |
| 2014-12-31 |
40.24 |
$1.07 |
37.61 |
| 2014-09-30 |
32.82 |
$1.02 |
32.18 |
| 2014-06-30 |
39.14 |
$1.15 |
34.03 |
| 2017-06-30 |
47.63 |
$1.12 |
42.53 |
| 2013-12-31 |
37.34 |
$1.27 |
29.40 |
| 2013-09-30 |
29.69 |
$1.29 |
23.01 |
| 2013-06-30 |
27.18 |
$1.40 |
19.42 |
| 2013-03-31 |
29.50 |
$1.38 |
21.38 |
| 2012-12-31 |
24.10 |
$1.37 |
17.59 |
| 2014-03-31 |
38.35 |
$1.34 |
28.62 |
| 2012-09-30 |
24.44 |
$0.13 |
187.98 |
| 2012-06-30 |
23.60 |
$0.10 |
235.97 |
| 2012-03-31 |
25.33 |
$0.04 |
633.26 |
| 2011-12-31 |
21.66 |
$-0.00 |
0.00 |
| 2011-09-30 |
19.41 |
$1.14 |
17.03 |
| 2011-06-30 |
24.03 |
$1.16 |
20.71 |
| 2011-03-31 |
22.17 |
$1.11 |
19.98 |
| 2010-12-31 |
22.30 |
$1.05 |
21.24 |
| 2010-09-30 |
18.91 |
$0.98 |
19.29 |
| 2010-06-30 |
15.72 |
$0.71 |
22.14 |
| 2010-03-31 |
20.09 |
$0.51 |
39.39 |
| 2009-12-31 |
19.24 |
$0.41 |
46.92 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$2.091B |
$1.245B |
|
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
|
